This Week in Managed Care—Trump Administration Continues to Unravel the ACA and Other Health News

Managed Care Cast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care stories included additional moves by the Trump administration to unravel the Affordable Care Act; Pfizer canceled a round of drug price increases after speaking to the president; advocates for 340B sound the alarm on efforts to reform the program. Read more about the stories in this podcast: Pause in Risk Adjustment Payments Announced, CMS Blames District Court's Decision: https://www.ajmc.com/newsroom/pause-in-risk-adjustment-payments-announced-cms-blames-district-courts-decision CMS Cuts Budget for ACA Marketing to $10 Million for 2019 Plan Year: https://www.ajmc.com/newsroom/cms-cuts-budget-for-aca-marketing-to-10-million-for-2019-plan-year What We're Reading: Pfizer Halts Price Increases; Azar's Attention Is Split; VA Pick Clears First Hurdle: https://www.ajmc.com/newsroom/what-were-reading-pfizer-halts-price-increases-azars-attention-is-split-va-pick-clears-first-hurdle 340B Health Says Changing Hospital Eligibility Will Slash Program: https://www.ajmc.com/newsroom/340b-health-says-changing-hospital-eligibility-will-slash-program Highmark Reaches Value-Based Contract for Empagliflozin, Fixed-Dose Combinations: https://www.ajmc.com/newsroom/highmark-reaches-valuebased-contract-for-empagliflozin-fixeddose-combinations